Somatrogon-ghla
- PMID: 37703102
- DOI: 10.1093/ajhp/zxad209
Somatrogon-ghla
Similar articles
-
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study.Front Endocrinol (Lausanne). 2023 Oct 17;14:1254424. doi: 10.3389/fendo.2023.1254424. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37955005 Free PMC article. Clinical Trial.
-
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment.J Pediatr Endocrinol Metab. 2023 Feb 3;36(3):261-269. doi: 10.1515/jpem-2022-0359. Print 2023 Mar 28. J Pediatr Endocrinol Metab. 2023. PMID: 36732285 Clinical Trial.
-
What do we do now that the long-acting growth hormone is here?Front Endocrinol (Lausanne). 2022 Aug 22;13:980979. doi: 10.3389/fendo.2022.980979. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36072938 Free PMC article. Review.
-
Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.Horm Res Paediatr. 2022;95(3):275-285. doi: 10.1159/000524600. Epub 2022 Apr 13. Horm Res Paediatr. 2022. PMID: 35417909 Free PMC article. Clinical Trial.
-
Effects of growth hormone and insulin-like growth factors on human osteoblasts.Eur J Clin Invest. 1998 Mar;28(3):184-6. doi: 10.1046/j.1365-2362.1998.00266.x. Eur J Clin Invest. 1998. PMID: 9568462 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources